►
From YouTube: CORONAVIRUS Q&A 12-9-2020
Description
No description was provided for this meeting.
If this is YOUR meeting, an easy way to fix this is to add a description to your video, wherever mtngs.io found it (probably YouTube).
A
Welcome
everyone:
this
is
mayor,
steve
hagerty
and
you
are
joining
our
evanston
coronavirus,
a
q,
a
session
that
we've
been
having
periodically
since
around
april
of
2020
our
year
is
quickly
closing,
and
I
think
it's
a
year
that
we
all
want
to
put
past
us,
but
as
we
close
the
year,
there
is
some
positive
news
on
the
horizon
about
vaccinations
with
covet
19..
I'm
pleased
today
that
we
have
as
our
guest
dr
rick
hubbard
rick,
and
I
go
back
to
our
days
serving
on
the
board
of
youth
and
opportunity.
A
United,
a
wonderful
youth
development
organization
here
in
evanston
and
rick
has
a
a
really
interesting
story
that
was
shared
in
the
evanston
round
table
a
couple
weeks
ago
that
I
thought
is
related
to
vaccines
and
should
be
something
that
we
talk
about
today.
So
I'm
pleased
to
have
dr
recovered
with
us.
We
also
have
with
us
ike
ogbo,
our
director
of
health
and
human
services
here
in
evanston,
who
has
been
doing
a
terrific
yeoman's
job
with
his
entire
team
to
try
and
keep
us
all
safe
here
in
evanston.
A
On
that
note,
I
do
want
to
quickly
run
down
with
everyone.
The
numbers
and
where
we
are
here
in
evanston,
as
everyone
knows,
the
numbers
have
been
rising
across
the
entire
united
states,
including
in
our
state
of
illinois.
The
governor
has
taken
mitigation
measures
to
reduce
the
amount
of
activity
that
we
all
have.
A
I
know
that
is
not
easy
for
all
of
us,
including
our,
including
our
children,
but
it
is
so
far
showing
a
an
effect
and
we
have
been
able
to
at
least
not
see
our
numbers
increase
and
so
we're
anxious
to
see
where
those
numbers
go
this
month,
particularly
given
that
we
just
had
thanksgiving
and
we're
entering
into
the
holiday
season,
with
with
hanukkah
coming
up
and
christmas
and
other
holidays.
A
So
where
we
stand
right
now,
our
region,
which
is
region
11,
ems
region,
11.,
our
positivity
rate
in
the
region,
is
12.7
percent
evans
and
that's
our
seven-day
positivity
evanston's
seven-day
positivity
right
now
is
the
highest
it's
it
has
been
in
recent
months,
and
that
is
at
eight
percent,
so
we
clearly
are
seeing
our
positivity
rate
go
up.
It
is
still
below
the
state
average
of
their
seven
day.
A
Positivity,
we
still
on
a
comparative
basis
in
terms
of
the
number
of
cases
for
ten
thousand
or
a
hundred
thousand,
are
continuing
to
do
well
relative
to
our
nearby
neighbors
in
skokie
and
the
city
of
chicago
lots
of
people
are
concerned
about
hospital
capacity
right
now
because
of
the
rise
in
cases.
A
They've
set
a
a
threshold
of
wanting
to
have
20
availability.
We
are
below
that
in
our
region
for
icu
beds
right
now
and
we're
just
about
20
a
little
above
20
percent
for
medical
beds.
The
good
news
right
now
over
the
spring
is
that
the
medical
profession
has,
you
know,
developed
more
knowledge
about
this
disease.
A
You
know
better
techniques
to
treat
people,
but
still
we
have
too
many
people
that
are
dying
of
of
covet
19,
including
88
deaths
to
date
here
in
the
city
in
the
city
of
evanston,
our
infection
rate,
which
is
the
rate
in
which
a
person
with
cobin
19
infects,
another
person
with
the
virus
is
at
around
1.0
right
now,
so
one
person
is
so
a
person
with
cover
19
is
affecting
one
other
person.
We
want
to
see
that
at
1.0
or
below
the
lower.
A
The
seven
day
moving
average
case
average
for
chicago
and
cook
county
has
been
decreasing.
I
will
say
right
now:
the
evanston
seven-day
average
is
pretty
high
for
evanston.
It
is
32.
Cases
is
our
seven-day
average.
Now
we
had
one
of
our
highest
cases
about
seven
days
ago,
which
was
63
cases
here
in
evanston,
so
that's
still
part
of
the
calculation
after
today.
I
believe
that
moves
out,
so
we
will
probably
see
that
32
cases
a
day
draw
on
average
for
the
last
seven
days
drop
down.
My
guess
is
to
around
23
to
25
cases.
A
As
I
mentioned
our
seven
day.
Moving
average
is
at
eight
percent
and
let's
see
the
last
thing
I
want
to
leave
you
with.
I
mentioned
the
hospital
capacity,
so
our
hospitals
in
this
area
still
continue
to
have
capacity
in
terms
of
icu
beds
in
meta
in
medical
beds
and
that's
both
amida
st
francis
hospital
on
the
south
side
of
evanston,
as
well
as
our
north
shore
university
health
system,
which
is
evanston
hospital
and
then
glenbrook
hospital
has
been
the
one
that
has
really
been
the
coven
19
hospital
for
the
north
shore
system.
A
And
lastly,
I
just
want
to
leave
you
with
our
long-term
care
and
our
congregate
facilities.
These
are
the
facilities
we
worry
about
the
most
because
they
have
older
evanstonians
living
there
generally
over
the
age
of
of
60
or
65.,
and
in
the
last
week
we've
had
22
staff
cases
in
those
congregate
facilities
in
36
resident
cases.
A
So
so
that's
a
quick
rundown
on
where
we
are
again.
Today's
topic
is
going
to
be
on
vaccines.
A
I
do
want
to
caution
the
audience
and
this
is
being
broadcast,
live
on
channel
16,
evanston's
public
station
as
well
as
on
facebook
live.
I
do
want
to
caution
everyone
that
as
much
as
we
want
to
have
concrete
information
on
vaccines,
we're
still
waiting
this
there's
a
lot
moving.
There's
a
lot
going
on,
there's
a
lot
of
different
authorities
involved
from
the
centers
for
disease
control
to
the
illinois
department
of
public
health
to
our
own
local
health
department.
A
So
we
are
going
to
try
to
answer
your
questions
today,
but
I
do
ask
for
patience
and
understanding
that
we
may
not
have
the
answers
yet
to
some
of
these
questions,
but
just
trust
that
we
are
very
much
working
closely
with
these
other
authorities.
The
cdc
illinois
department
of
public
health
to
understand
when
we
may
be
receiving
these
vaccines
and
how
we
need
to
think
about.
You
know
who's
getting
these
vaccines
first,
second,
third,
and
how
we
would
actually
distribute
those
vaccines.
So
ike
ogbo
is
going
to
help
us
today
on
those
on
those
questions.
A
So
let's
get
a
go
ahead
and
get
our
panel
started.
First,
I
want
to.
I
want
to
turn
to
dr
hubbard
and
just
asked
doctor
if
you
would
share
your
background
with
our
community,
because
I
think
it's
a
really
interesting
and
relevant
background
to
what
we're
going
through
right
now,
as
well
as
how
you
came
to
participate
as
one
of
the
trial
participants
in
the
test
for
these
vaccines
welcome
rick.
B
Thank
you.
Doctor.
Excuse
me,
mr
mayor,
it's
pleasure
to
be
here
and
share
my
experiences
with
with
the
evanston
community.
I'm
a
research
physician.
B
I
worked
for
30
plus
years
with
a
pharmaceutical
company
starting
with
searle
and
ending
up
with
pfizer,
and
I've
also
done
research
at
the
nih
doing
clinical
research
and
drug
development
for
all
the
entire
career
and
right
now,
I'm
semi
retired
and
working
for
northwestern
university
institutional
review
board
reviewing
medical
clinical
trials.
B
I
came
to
be
involved
with
the
moderna
trial
because
I've
always
been
interested
in
clinical
trials.
Obviously
because
of
my
background,
but
also
I
wanted
to
participate
to
sort
of
give
something
back
to
the
community
in
terms
of
personal
experience
and
understanding
that
more
than
anything
else,
they've
been
asking
for
older
black
subjects
or
patients
or
individuals
to
be
in
the
clinical
trials.
So
when
I
found
out
about
the
clinical
trials
last
summer,
I
think
I
found
out
simply
by
googling
clinical
trials
of
clinical
vaccine
trials.
B
Downtown
I
contacted
them
and
a
week
later,
they
responded
asked
me
about
my
background,
my
health
status,
etc,
and
if
I
would
be
willing
to
be
in
the
trial-
and
I
said
yes
about
a
week
later-
I
went
down
to
the
clinical
trial
site
run
by
dr
novak
and
associates
at
the
university
of
illinois,
and
I
had
my
first
session
with
them,
which
involved
a
physical
examination,
reviewing
the
informed
consent
process
and
answering
any
questions
that
I
might
have
about
the
trial,
some
blood
tests,
the
nasal
swab
for
for
the
vaccine
was
done
and
when
all
that
was
done,
I
got
my
first
injection.
B
B
The
next
step
was
to
come
that
followed
up
with.
They
gave
me
an
electronic
diary
for
my
cell
phone
and
every
day
I
would
fill
out
the
seven
or
eight
questions
on
the
electronic
diary
just
to
see
how
I
was
doing
if
there
had
been
any
reactions
to
the
shot,
etc
and
then
one
month
after
the
original
shot,
I
went
back
to
get
my
second.
C
B
Went
through
the
whole
process
again
similar
to
the
first
time-
and
I
got
my
second
shot-
went
home
filled
out
the
diary
again
on
my
cell
phone
for
another
seven
days
and,
and
that
was
it
for
the
start
now
part
of
the
process
of
being
in
the
clinical
trial.
Is
you
have
to
be
pretty
aware
of
any
symptoms?
B
You
may
have
either
what
you
think
is
a
reaction
to
the
shot
or,
if
you
think
you
might
be
coming
down
with
covid
type
symptoms,
so
you
have
to
be
pretty
aware
of
that,
and
you
have
to
call
up
the
study
staff
when
you
think
you
might
be
coming
down
with
something.
B
A
B
Have
to
go
back
down
downtown
and
drew
some
more
samples,
etc,
which
came
back
a
few
days
later.
Unfortunately,
they
were
all
negative,
so
I
did
not
come
down
with
a
episode
of
covert
19
so
far
on
the
trial,
and
it's
been
about
since
beginning
of
september,
when
I
got
my
first
shot
until
now,
so
it's
been
almost
six
months.
B
B
That
would
go
on
for
two
years,
because
the
idea
is
they
want
to
know
how
long
the
effect
may
last
from
the
shot
and
any
other
safety
issues
that
may
come
after
after
a
while.
So
the
the
original
plan
was
for
two
years
follow-up,
I
think
now
that
the
drugs
or
the
vaccines
are
being
approved.
They
may
shorten
that
follow-up
period,
but
it
hasn't
been
determined
directly
yet
how
that
process
will
unfold.
B
So
I
don't
think
they'll
be
following
me
for
two
more
years
at
some
point
I'll
find
out
whether
I
got
the
placebo
or
the
vaccine.
I
don't
know
which
I
have
my
suspicions,
but
I
don't
know
for
sure
and
in
fact
the
staff
at
the
center,
where
I
got
my
shots,
they
don't
know
either
the
only
ones
who
know
who
got
what
are
the
folks
at
moderna
who
have
the
sort
of
code
as
to
what
kind
of
treatment
people
received.
B
So
I'm
still
in
the
blind,
I'm
still
blind
about
what
I
got,
but
I'm
hoping
I
did
get
the
vaccine
the
active
one,
but
we'll
have
to
wait
and
see.
A
Right
and
so
that
that,
because
it's
a
blind
study-
and
you
don't
know
if
you
got
a
placebo
or
the
actual
vaccination,
that's
why
again,
if
you're
developing
any
symptoms,
you
have
to
reach
back
out
immediately
to
to
the
to
the
team,
and
it
shouldn't
be
that
you
know
anybody
thinks.
Oh,
he
had
the
symptoms,
even
though
he
was
testing.
He
didn't
have
it
that
aha,
the
vaccine
doesn't
work,
I
mean,
can
you
talk?
Can
you
talk
dr
hubbard,
just
as
a
scientist,
particularly
in
somebody
who
has
worked
in
this
field?
A
Your
whole
career
about
whether
we
ought
to
you
know
can
rely
on
these
types
of.
You
know,
studies
that
are
being
done
because
I
know
there's
some
people
that
do
have
some
concerns
because
of
the
accelerated
pace
in
which
we're
doing
these,
and
we
certainly
here
in
evanston,
you
know-
want
people
to
have
faith
and
trust
in
what
is
approved
by
you
know
the
the
fda
and
that
we
are
going
to
be
bringing
here
locally.
I'm
sorry,
I
just
like
your
thoughts
on
that.
B
B
So
it's
all
telescoped
into
the
final
one
year
period
that
the
technologies
etc
have
been
worked
on
by
scientists
for
at
least
10
years,
and
they
started
being
worked
on
with
the
sars
episode
of
ten
years
ago,
when
people
were
concerned
that
there
might
be
a
new
viral
outbreak.
So
that's
when
the
technologies
were
first
used
and
now
the
same
platforms
are
used
for
this.
B
B
Now
whether
the
public
can
trust
this
kind
of
approach,
I
think
I
certainly
trusted
it
or
I
wouldn't
have
put
myself
in
the
position
of
going
into
the
clinical
trial.
I
know
very
well
how
research
works,
and
I
know
the
companies
that
are
doing
their
research
have
good
reputations
and
good
scientific
procedures
as
to
how
to
do
this,
and
I
have
ultimate
faith
in
the
fda
as
far
as
how
they
are
evaluating
this
information.
B
Sometimes
it
appears
as
though
all
we
know
is
from
a
press
release
and
that's
that's
regrettable,
but
I
was
just
reading
through
the
150
pages
of
the
fda's
summary
of
the
pfizer
vaccine
and
it's
very
thorough
and
I'm
sure
that
information
well
it's
available
on
the
website.
So
anybody
who
wants
to
know
in
detail
about
the
safety
and
effectiveness
of
the
vaccine,
you
can
go
onto
the
fda
website
and
see
the
information
on
your
own
without
the
filter
of
the
of
a
press
release.
B
So
I
think
the
process
well,
it
seems
to
be
a
bit
mysterious
for
much
of
the
time
the
information
will
be
made
available
and
the
the
decision
about
whether
the
vaccines
are
effective
and
safe
will
be,
I
think,
transparent
to
everybody
once
that
information
is
is
released
and
in
the
pfizer
case
it
was
released
yesterday
and
it
will
be
discussed
by
the
fda
tomorrow
and
I
think
by
friday,
we'll
have
a
decision,
so
I
think
we
can
all
feel
comfortable.
A
Thank
you.
Thank
you
doctor.
You
know.
I
have
a
lot
of
faith
and
confidence
in
dr
fauci
and
also
these
independent.
You
know
regulatory
authorities
and
the
fact
that
you
know
there
are
other
countries
who
are
very
developed
countries
like
england,
like
canada,
that
are
putting
these
vaccines
through
their
process.
You
know
makes
me
feel
you
know
feel
better.
I
will
remind
everybody
what
dr
fauci
said
on
a
conference
call
that
I
was
on
and
all
these
other
mayors
from
across
the
country
a
while
back
is
he
said.
A
A
If
we
can
accelerate
the
development,
you
know
fast
enough,
but
still
safe
to
get
it
out
to
the
public,
and
he
said
I-
and
this
was
back
in
in
the
summer
when
we
were
on
this
call-
and
he
said
I
you
know
if
we're
lucky
and
we
get
a
couple
breaks
and
everything
we
will
have
a
vaccine,
hopefully
in
january
or
february,
if
we
don't
get
those
breaks
and
everything
else,
it
may
not
be
until
september
or
october,
and
so
you
know
it
looks
like
right
now.
A
If
we
get
fda
approval,
we
could
see
it
within
the
next
week
being
approved
here
in
the
united
states,
but
I
just
want
to
share
again
with
people
what
dr
fauci
said
to
me
and
hundreds
of
other
mayors.
You
know
on
this
conference
call:
we've
got
lots
of
questions
that
people
are
submitting
and
and
you're.
Please
do
that
if
you're
on
facebook
live
so
we're
going
to
now
hit
the
questions,
let's
try
to
get
through
them.
We've
got
a
lot
of
questions,
so
I'd
like
to
try
to
get
them
answered.
A
We've
got
about
35,
more
minutes,
so
ike,
let's
start
off
with
you.
First,
how
is
the
city
preparing
and
planning
for
vaccine
distribution.
C
Absolutely
so
for
months,
the
city
has
been
preparing
for
mass
vaccination
of
our
residents
and,
of
course,
staff,
and
what
that
entails
is
taking
a
look
at
the
recommendations
and,
of
course,
collaborating
with
cdc,
idp,
h
and,
of
course,
our
community
partners,
who
will
of
course
help
and
aid
in
our
vaccination
plans.
And
what
he
actually
has
also
happened
is
that
we
are
revising.
As
information
reaches
us.
As
we
know,
this
is
ever
evolving
and
we
are
updating
our
vaccination
plans
with
the
latest
developments
and
the
pieces
of
information.
C
But
the
vaccination
plan
that
we
have
developed
covers
an
aspect
of
strategies
ranging
from
transportation
story,
demonstration,
distribution
and,
of
course,
reporting,
and
it
does
take
a
lot
of
work
to
work
through
the
kinks
of
this.
You
know,
given
that's
the
information
is
always
changing,
so
we
are
keeping
updates
with
the
state
with
cdc,
collaborating
with
them.
C
In
regards
to
our
vaccination
plan-
and
I
know
there
have
been
questions
directed
to
me
and
and
staff-
and
perhaps
you
may
have
as
to
who
is
going
to
be
getting
these
vast
things-
and
it
is
in
the
news
given
that
we
do
have
some
priority
groups
who
will
be
getting
the
vaccine
first
before
it
goes
to
the
general
public.
C
The
general
public
will
eventually,
of
course,
get
the
these
vaccines,
but
the
focus
right
now
will
be
those
who
are
the
most
impacted
by
bike,
19
and,
of
course,
our
frontline
staff,
which
of
course
are
healthcare
workers.
But
these
are
items
that
we
are
still
flushing
out
so
that
we
are
pretty
much
in
line
with
the
cdc
guidance
and
idp
h
guidance,
so
that
we
can
tailor
our
plans
to
remain
in
the
confines
of
those
those
guidance
and
recommendations.
A
Thank
you
mike,
and
I
just
want
the
general
public
to
know.
You
know
you
have
my
word
and
the
city
manager
who's
not
here
with
us
today,
but
that
we
are
going
to
continue
to
try
and
share
information
as
quickly
as
we
have
good
information
to
share
with
the
public,
and
I
know
again,
many
people
are
anxious
about
finding
out
how
vaccines.
A
Just
you
know,
distribution
will
occur,
what
the
priorities
will
be
here
and
everything
else.
We
don't
have
those
specifics
right
now,
but
I
think
you
can
look
at
what
other
countries
are
doing
just
like
ike
said
with
health
care
professionals,
first,
those
most
at
risk
second,
and
think
we're
going
to
see
something
similar
here
in
evan
and
evanston,
dr
hubbard,
we
had
a
question
for
you,
sue
who's
watching
asked.
Have
you
been
staying
at
home?
A
B
I
have
been
staying
at
home
for
the
most
part,
although
I
do
go
out
consistent
with.
I
think
governor
pritzker's
recommendations
about
about
sheltering
at
home
appropriately,
but
I
go.
B
B
I
do
social
distancing
when
I
go
out
so
the
only
way
to
know
if
it's
the
vaccine
is
working
or
if
it's
just
my
being
a
careful
person,
is
to
do
a
clinical
study
where
you
have
thousands
of
people
living
their
daily
lives
and
the
law
of
averages
or
the
law
of
just
a
sheer
number
of
people
will
give
you
an
answer,
an
individual
answer.
I
can't
tell
you
yeah.
I
can't
tell
you
whether
my
being
killed.
A
No,
the
video
paused
and
I
was
trying
to
also
ask
you
another
question:
can
you
talk
as
both
a
scientist
and
someone
in
in
this
study
about
efficacy
rates
and
what
that
and
what?
That
means
because,
like
you
said
there
are
thousands
of
people
participating
and
they
do
in
a
sense,
want
you
to
follow
the
rules
that
are
going
on
that
we're
all
following,
but
they
also
want
you
to
go
about
sort
of
living.
Your
life
as
well.
I
believe.
B
Yeah
they
want
us
to
live
our
lives,
as
we
normally
would,
and
the
effectiveness
rate
that
we
have
seen
is
based
on
a
small
number
of
infections,
really
in
the
40
000
person,
trial,
they're
reporting,
at
least
pfizer's
reporting-
that
their
data
is
based
upon
about
150
infections.
B
Only
of
the
40
000
people
who
are
in
the
study
and
of
those
limited
number
of
infections,
95
percent,
of
which,
let
me
just
say,
the
95
of
the
infections
occurred
outside
of
the
people
who
got
the
vaccine.
B
A
B
Where
they
get
the
effectiveness
rate,
it's
it's
important
to
understand
that
they're,
not
looking
it's
not
based
upon
all
40
000
people,
it's
based
upon
the
95
or
150,
or
so
who
actually
got
an
infection
and
how
effective
it
was
in
preventing
the
infection
in
those
those
people
who
were
so
impacted.
B
Yeah,
it's
a
little
bit
hard
to
understand,
but
it's
based
on
a
small
number
of
people
who
actually
did
get
infected
and
that's
why
the
trials
have
to
be
so
large
in
order
to
get
us
a
reasonable
number
of
symptomatic
infections
to
make
a
scientific
basis.
A
On,
indeed,
thank
thank
you
for
that.
Mike
we
have
a
question
from
renee
and
again
some
of
these
questions
will
be
vaccine
related.
Some
will
not
be
so
we're
just
going
to
try
and
get
through
them.
I
want
to
try
and
get
through
them
fast,
so
we
can
get
people's
answer.
She
she
appreciates
you
and
your
office
holding
the
drive
through
flu
shots
that
we
had
this
year.
A
C
Yeah,
absolutely
we
are
exploring
all
options
at
this
point.
We
are
looking
into
having
some
indoor
events,
outdoor
events
and
we
haven't
ruled
out
drive-through
events
because
they
were
very
instrumental
in
getting
people
vaccinated
or
tested.
So
we
are
looking
at
what
would
be
the
most
feasible
and,
of
course,
part
of
our
plans.
It
will
be
including
drive-through
testing,
I
believe,
also
depend
on
the
month
in
which
we
get
these
vaccines
for
for
the
general
public.
A
All
right,
so
so
all
mechanisms
are
still
on
the
table
in
terms
of
how
we
might
vaccinate
people
here.
Okay,
we
had
a
question
from
fred,
I'm
going
to
ask
you
ike,
because
I
think
dr
hubbard
has
talked
about
this
a
little.
So
let
me
ask
you
this
question:
how
safe
are
the
pfizer
and
the
modern
vaccines
fred
wants
to
know.
C
Right,
absolutely
and
as
dr
hubbard
was
elaborating
and
explaining
the
efficacy
of
the
vaccines
when
it
comes
to
the
fires
of
that
scene,
that
has
an
efficacy
of
about
95
percent
modena.
They
are
reporting
about
94.5,
which
is
pretty
much
almost
the
same,
which
I
I
believe
will
be
very
keen
for
individuals
to
consider
to
say:
okay
well,
if
it's
providing
this
much
of
efficacy
and
effectiveness,
I'll
be
able
to
see
that
because
they've
gone
through
all
these
trials
and
I'll
feel
more
confident
and
comfortable
to
take
these
messages.
C
So
the
vaccines
has
gone
through
a
number
of
trials.
Although
it
has
been
spared,
it
has
been
accelerated,
but
we
believe
that
the
prominent
step
will
be
manufactured
and
once
it's
approved,
that
will
be
safe
for
the
general
public
to
have
those
vaccines
administered,
and
it
is
something
of
course
that
we
will
encourage
strongly
for
the
general
public
to
to
consider
just
based
on
the
percentages.
The
percentages
at
this
point
is
very,
very
promising,
and
I
remember
when
they
were
still
in
the
process
where
they
were
saying
it
was
about
50
efficacy.
C
I
I
think
people
will
be
more
keen
to
take
the
vaccine,
so
we're
very,
very
confident
and
of
course,
people
are
asking
what
you
know
the
long-term
care
the
long-term
effects
will
be
in
regards
to
this
vaccine.
It
is
yet
to
be
seen.
They
have
indicated
a
number
of
symptoms
that
might
be
associated
or
number
of
health
effects
that
might
be
associated
with
the
vaccine,
which
might
be
fatigue
might
be.
C
Headaches
might
be
just
the
pain
that
you
get
when
you
you
take
the
vaccine,
but
with
any
with
any
vaccine
that
you
take.
There
are
these
dvd
defects
with
them,
so
we
will
certainly
encourage
and
we'll
have
a
campaign
to
rally
and
get
people
to
our
vaccination
events,
because
this
is
very
important.
A
If
they,
if
they
said
ike,
that
mayors
are
going
to
be
first,
it
can
be
can
be
in
line.
First
I'd
be
the
first
one
up
there,
I'm
ready
I'm
ready
for
this
vaccine.
I
have
a
lot
of
faith
again
and
trust
in
all
of
the
different
independent
regulatory
bodies
that
are
going
to
make
decisions.
We
did
have
a
question
from
rosalie
and
I'm
going
to
ask
rick
real
briefly.
A
B
So
I
do
have
some
direct
experience
with
the
fda.
I've
been
on
a
couple
advisory
committees
when
I
was
developing
drugs
and
I
know
how
the
scientists
are
chosen
and-
and
I
have
no
question
about
the
scientific
independence
of
the
of
the
people
who
are
making
the
decisions.
B
I've
also
had
experience
with
some
of
the
other
agencies
in
france
and
in
europe
and
in
canada,
and
they
go
through
the
same
process
and
when
all
of
those
agencies
independently
come
to
pretty
much
the
same
conclusion.
I
think
that
also
gives
us
more
comfort
that
it's
a
science-based
decision
and
not
a
political-based
decision.
B
So
I
there's
a
lot
of
noise
about
getting
these
things
done
quickly,
and
I
I
think
the
scientists
are
going
to
be
independent
about
this
and
they
will
do
their
best
because
they
are
charged
with
doing
that
and
they
want
to
make
sure
there's
no
mistakes
made
that
can
impact
the
health
of
a
lot
of
people
who
are
going
to
get
these.
A
Thank
you
anything
you
want
to
add
to
that.
No
all
right!
We
got
plenty
of
other
questions.
Let's
let's
go
with
this.
I'm
gonna
ask
this
of
of
rick.
If
he
has
a
sense,
because
I
think
he's
been
looking
at
the
different
vaccines
as
well,
what
is
no.
This
is
from
charles.
What
is
known
at
this
point
about
the
various
reactions
that
exists
to
different
vaccines.
B
It's
hard
to
know,
I
only
know
what
they
said
about
the
moderna
one
and
the
pfizer
one,
and
as
far
as
I
can
tell,
the
vaccine
reactions
are
about
the
same
as
you
would
get
with
any
other
vaccine.
You
get
a
sore
shoulder,
sometimes
where
the
shot
was
given.
B
You
may
get
a
headache,
a
fever
for
a
day
or
so
these
things
are
all
self-limiting
and
they're,
just
typical
of
any
vaccine
that
you
would
get,
even
though
the
technology
is
new
and
different,
there's
every
reason
to
believe
it's
equally
or,
if
not
safer
than
the
older
vaccines.
We're
more
familiar
with
these
vaccines.
B
The
pfizer
and
the
modern
ones
are
giving
instructions
to
your
cell
to
make
a
to
react
in
the
presence
of
the
virus.
So
it's
instructing
the
cell
here.
If
you
see
a
virus,
here's
what
you
should
do,
it's
almost
like
apple
or
google,
sending
instructions
to
your
computer
to
work
on
to
to
recognize
viruses
and
to
block
them
out.
So
I
think
it's
very
safe.
B
A
Thank
you.
Thank
you.
We've
got
a
couple
questions
from
sheila
I
come
and
ask
if
you
want
to
take
the
first
shot
at
these
first
question
from
sheila.
Is
the
cova
19
vaccine
recommended
for
people
with
autoimmune
disease.
C
Yeah,
that's
a
that's
a
loaded
question
as
it
stands.
We
have
these
vaccines
and,
of
course
it
is
something
that
is
recommended,
but
also
we
are
going
to
wait,
wait
and
see.
I
know
there
have
been
some
talks
about
whether
someone
who
gets
the
vaccination
will
be
able
to
still
spread
the
virus
and
that's
actually
a
possibility,
so
we'll
continue
to
see
the
normal
when
face
coverings
and
social
distancing,
even
with
individuals
who
have
been
vaccinated.
C
So
when
it
comes
to
autoimmune
diseases
and
whether
that
person
can
be
vaccinated,
I
think
there's
still
research
on
the
way
just
for
the
researchers
and
the
medical
experts
and
the
public
health
expos
to
really
get
a
grasp
of
what
does
that
scene
can
possibly
do
and,
as
we
know
it
is
normal.
It
is
it's
new.
C
It's
not
like
anything
that
we've
seen
before,
so
they
are
still
a
number
of
questions
that
are
still
lingering
at
these
answers
to
and
I
believe
that
will
be
one
of
those
as
well,
but
as
it
stands
and
as
you
perhaps
know
mayor,
the
participants
for
the
trials
were,
of
course
adults,
and
I
know
there
were
some
questions
about.
You
know
the
children
and
what
have
you,
but
they
weren't
those
those
that
were
included
in
in
the
trial.
B
Yeah
with
regard
to
under
underlying
diseases,
people
with
underlying
diseases
were
encouraged
to
participate
in
the
study.
So
if
you
had
an
autoimmune
disease,
that
was
not
an
exclusion
criteria,
so
there
probably
were
some
people
who
received
the
vaccine,
who
may
have
an
autoimmune
disease.
We
don't
know
yet
until
the
blind
is
broken
and
all
that
data
is
released,
we
don't
know
yet,
but
they
certainly
there
are
people
who
are
evaluated,
who
did
have
underlying
diseases
and
when
the
full
data
is
released
from
say,
75
000
individuals.
A
Thank
you.
I
would
just
add
that
again.
This
is
all
moving
very
quickly
they're
going
to
be
specific
questions
that
many
people
have
and
that
these
are
are
these
medical
questions
should
absolutely
be
directed
to
your
medical
doc
to
your
medical
doctor
for
these
and
they
again
all
the
medical
profession
are
getting
up
to
speed
on
these
as
well,
just
like
all
of
us
are,
but
they
get
to
see
more
of
the
research
and
everything
else
than
than
the
average
person
probably
does
another.
Last
question
from
sheila
ike.
C
So
that's
that's
a
good
question
when
it
comes
to
the
vaccine.
As
I
mentioned
it's
normal.
C
We
are
still
learning
about
the
disease
learning
about
the
vaccine,
but
I
don't
see
at
this
point
cdc
relaxed
in
any
of
the
preventative
protocols
or
abandoning
the
protocols
that
we've
been
using
throughout
the
pandemic,
which
is
of
course
quarantined
and
making
sure
that
you're
wearing
your
face
coverings
when
you're
within
six
feet
of
individuals
and
of
course,
hand
washing
and
staying
home
while
you're
sick.
So
I
don't
think
that
they
will
be
relaxing
those
recommendations.
C
So
when
it
comes
to
quarantine,
I
I
believe,
even
though
you
are
vaccinated,
there's
still
a
possibility
for
you
to
to
spread
the
virus.
So
in
that
regard,
you'll
still
be
encouraged.
C
It
will
still
be
a
recommendation
that
we
continue
to
apply
these
methods
that
we've
been
using
throughout
the
pandemic,
even
when
we
get
vaccinated
and
until
we
gather
as
much
information
as
possible
to
see
if
people
are
able
to
to
confidently
state
that
they've
they've
gotten
the
disease,
even
when
someone
has
been
vaccinated,
but
as
it
stands
right
now,
the
recommendation
would
be.
C
A
I've
I've
read
some
articles
recently
that
have
made
that
very
clear
that
public
health
protocols
aren't
going
to
go
by
the
wayside.
Just
because
we
start
to
vaccinate
people
you'll
still
even
have
vaccinated,
be
expected
to
wear
a
mask,
and
all
of
that
just
remember
what
we're
trying
to
do
with
this
virus
is
we're
trying
to
smother
it.
A
C
Absolutely
and
and
vaccines
is
just
one
of
those
tools
to
use
to
subdue
limit
or
entirely
remove
the
virus,
so
those
public
health
protocols.
We
cannot
emphasize
enough.
Those
still
need
to
be
in
place
even
with
their
scene
that
it
is
in
a
horizon.
So
people
need
need
to
need
to
understand
that
I'm
getting
that
scene
of
course
you're
protecting
yourself,
but
there's
still
that
possibility
of
you
being
able
to
spread
the
the
virus
to
others.
So
I
just
want
people
to
make
note
of
them.
Make
no.
A
Thank
you,
I'm
looking
at
the
questions.
We
have
some
that
are
really
really
technical,
that
I
don't
think
we
have
the
answers
for
right
now,
so
I'm
not
even
going
to
pose
them,
but
in
a
future
coronavirus
q.
As
we
learn
more
information,
I
I
may
ask
them
at
that
point.
We
have
a
question
from
betty
who
says
my
husband
and
I
are
in
our
70s
and
are
temporarily
living
in
las
vegas.
A
C
In
that
regard,
we
are
expecting
for
the
vast
scenes
to
be
available
at
our
pharmacies
at
medical
providers.
You
name
it
that
anyone
can
access
these
vaccines
anywhere
in
the
country.
The
first
batch
of
vaccines,
of
course,
are
going
to
be
limited
and
those
are
going
to
go
to
some
priority
groups,
but
throughout
2021
there
will
be
ample
vaccines
available
so
that
anyone
can
go
to
like
these
places.
I
mentioned
to
get
to
get
vaccinated,
but
important
right.
A
C
It
depends
it
depends
on
the
plans
that
they
have
in
place
in
las
vegas
if
they
will
fall
in
that
priority
group.
But
I
am
thinking
that
luxurious.
Those
will
be
following
the
cdc
guidelines
are
prioritized
in
various
groups
so
that
those
individuals
who
are
in
las
vegas
can
get
the
vaccine
that
that
they
need,
but
it
all
depends
on
what
strategies
and
methods
that
they
have
in
that
las
vegas.
C
But
given
that
their
age
and
if
there
are
any
medical
conditions
that
they
might
be
experiencing,
they
will
be,
of
course
prioritized,
but
they
might
not
fall
into
the
tier
one
priority
group.
They
might
fall
into
the
third
priority
group,
but
they
will
be
able
to
get
the
vaccines
when
those
vaccines
are
made
available.
For
that
particular
group.
A
Okay,
I
got
a
question
from
suzanne,
I'm
gonna
turn
to
you
and
a
doctor
hubbard
on
this
to
see.
If
you
know,
if
you
don't
know
the
answer,
just
go
ahead
and
say
she
asked
do
the
pfizer
and
moderna
vaccines
prevent
asymptomatic
transmission,
if
not
how
long
until
nasal
vaccines
become
available
which
could
potentially
solve
this
problem.
B
B
A
That
that
is
consistent
with
what
I
have.
What
I
have
read
as
well,
and
one
of
the
reasons
why
the
public
health
authorities
are
clear
that,
even
though
we're
going
to
start
to
vaccinate
soon,
the
public
health
protocols
of
social
distancing
wearing
a
mask.
All
of
that
is
still
going
to
apply
because
they
don't
know
enough.
Yet
about
the
asymptomatic
transmission
of
this.
B
A
Okay
idea,
anything
you
want
to
add
on
that,
I'm
going
to
go
to
the
next
question
from
suzanne.
A
B
Well,
yeah,
that's
one
of
the
it's
a
big
big
question.
I
mean
the
longest
people
have
been
observed.
Having
gotten
one
of
the
leading
vaccines,
it's
probably
under
a
year
the
fda
had
required
required
that
they
wouldn't
consider
any
vaccine
that
had
less
than
two
months.
Exposure
data
two
months
is
pretty
short.
So
that's
one
of
the
reasons
why
originally,
when
I
signed
up
for
the
city,
they
said
we're
going
to
evaluate
you
for
two
years
to
see
if
there
are
any
long-term
effects.
B
A
Thank
you,
dr
hubbard.
Will
the
coven
19
vaccine
vary
in
effectiveness
season
to
season
like
the
flu
vaccine
does
dr
harper?
Do
you
want
to
take
the
first
crack
at
that?
One.
B
Again,
we
probably
don't
know
yet
we
don't
know
if
there's
a
seasonality
to
this.
It's
a
suspected
that,
like
most
respiratory
viruses,
they
are
more
prevalent
in
the
cold
weather
months
than
in
the
warm
weather
months.
B
The
thing
about
the
flu
vaccine,
though,
why
it
why
it's
a
little
bit
different
is
that
it
mutates
very
quickly,
so
the
flu
vaccine,
that
the
flu
that
you
get
this
year
may
not
be
the
same
bug
that's
going
around
next
year
or
last
year,
because
there's
mutations
and
that's
why
you
have
to
get
a
annual
flu
shot,
because
the
flu
shot
is
going
to
be
a
little
different
based
upon
how
the
bug
is
mutated.
B
A
The
corona-
I
think
this
is
important
and
I
don't
know
if
I
know
the
answer.
I
think
I
do,
but
I'm
not
sure
the
corona
virus
in
cova
19
is
part
of
a
family,
I'm
just
a
non-medical
term.
I'm
going
to
use
as
part
of
a
family
of
viruses
that
we
and
scientists
have
been
studying
for
quite
some
time
is
that
is
that
correct?
I
mean
the
sars
h1n1
all
of
those
and
so
again,
while
it's
novel
and
they
haven't
seen
this-
it
comes
from
a
family
that
they're
familiar
with.
C
That
is,
that
is
absolutely
true.
It
does
come
from
a
family
of
coronaviruses
and
that's
where
you
have
sars
and
mars
and
and
of
course,
in
the
corbett
19.,
and
when
we
were
responding
to
covet
early
in
the
pandemic.
C
We
were
pretty
much
following
the
recommendations
that
were
established
for
mars
and,
of
course,
stars
are
because
they
pretty
much
are
in
that
same
family
and
the
way
that
they
transmit
that
the
virus
is
pretty
much
in
the
same
fashion.
So
you
are
correct.
They
are
within
the
same
family,
but
of
course
they
do
have
variations
and
they
do
have
different
strains,
but
this
particular
strain.
This
particular
virus
has
been
a
virus
that
we
have
not
experienced
before
and
that's
why
it
has
been
quite
quite
difficult
and
of
course,
when
you're
talking
about
vaccines.
C
C
We
were
able
to
establish
or
have
a
vaccine,
because
it
is
a
virus
that
we
have
dealt
with
before,
although
the
strain
might
have
been
a
bit
different,
but
we
already
had
that
vaccine
in
place
with
this
particular
virus
and
the
strain
we
have
not
experienced
it
before.
No
vaccines
have
been
licensed.
C
No
vaccines
have
been
manufactured
or
licensed
to
do
with
this
particular
virus,
and
that's
why
it
has
been
taken
quite
a
long
time
to
develop
a
specific
fire,
a
specific
vaccine
for
this
particular
virus
and,
as
you
remember,
with
h1n1,
we
were
able
to
secure
a
vaccine
within
a
matter
of
months
right
because
we
already
had
the
annual
flu
vaccine
that
is
quite
similar
to
that
new
strain
of
h1n1,
so
that
people
got
fascinated
early
enough.
C
So
I
think
that
I
don't
know
if
I
I
was
able
to
address
that
question
there,
but
yes
you're
right,
they
do
fall
within
the
corona
virus.
Family
discovered
194
within
that
family.
But
with
that
family
you
also
have
other
current
vibes,
even
the
common
code
that
you
experience
also
falls
within
that
that
family.
I
don't
know
if
dr
hubbard
has
anything
to
add
to
that.
B
I
I
agree:
it's
part
of
a
family
and
you
can
see
what
the
family
in
general
does
with
regard
to
seasonality,
and
you
can
expect
that
this
one
will
behave
pretty
much
like
the
others,
but
again
because
it's
novel,
it's
new.
A
I
guess
my
point
in
asking
that
question
was
my
level
of
confidence
in
the
work
that
is
being
done
by
scientists
and
these
regulatory
bodies,
and
all
of
that
is
elevated,
is
increased
because
it's
not
like
this
is
an
entirely
new
virus
of
a
family
they're
not
even
familiar
with
like
we're
familiar
with
the
family.
We've
been
studying
the
family
for
a
long
time
and
there's
something
different
about
this
one.
A
A
So
I
think
we're
we're
about
up
on
our
our
hour.
There
was
one
more
question
that
suzanne
had,
I
think
we've
talked
about.
I
think
dr
hubbard
answered
this.
She
asked:
will
the
pfizer
vaccine
trial
results
be
made
public
moderna
pfizer,
correct
me
if
I'm
wrong,
but
you
said
that
they
would
be
made
public
at
some
point,
but
that
won't
be
until
the
the
trials
are
completely
you
know
done
I
mean
their
concern.
A
Is
how
can
we
trust
the
company's
press
releases,
which
is
all
we're
seeing
right
now
and
if
you
want
to
just
end
with
that
one
dr
hubbard.
B
Yeah,
my
understanding
is
that
the
fda
will
publish
the
data
on
their
website
and
it
won't
be
in
the
form
of
a
press
release.
It
will
probably
be
rather
dense
scientific
documents,
so
it
will
be
available
at
some
point
in
route,
probably
pretty
soon,
and
I'm
sure
that
both
pfizer
and
mcdinner
will
want
to
have
a
peer-reviewed
article
come
out
in
a
leading
medical
journal,
summarizing
the
data
as
well
so
yeah.
B
I
know
at
the
moment
all
we
see
are
press
releases,
but
I'm
confident
that
at
some
point
in
the
not
too
distant
future,
we'll
have
the
available
data
in
primary
form.
To
look
at
should
be
so
choose.
A
And
I
would
add
that
all
of
the
regulatory
bodies,
whether
they're
in
the
united
states
or
they're
in
europe
or
other
countries,
are
getting
the
data
they
are
look.
They
are.
You
know
able
to
look
at
the
data
able
to
look
at
exactly
how
these
studies
were.
You
know
crafted
and
implemented
in
all
of
that,
so
the
decisions
made
by
these
regulatory
bodies
are
not
getting
made
off
of
of
press
releases
or
anything
like
that.
A
It's
being
you
know,
it's
being
made
off
of
data
and
science
and
expert
you
know,
opinion
of
people
like
dr
hubbard
who's
sat
on
some
of
those
committees
and
others.
Similarly,
so
I
want
to
thank
everyone
for
joining
us.
I
know
this
is
a
timely
topic.
A
I
know
it's
a
topic
that
we
will
continue
to
talk
about
in
in
the
months
ahead,
as
we
get
more
information,
as
I
mentioned
in
the
show,
once
we
have
a
good
understanding
of
exactly
you
know
what
the
rules
are
going
to
be
that
come
down
from
cdc
to
the
illinois
department
of
public
health,
to
our
local
department
of
public
health,
we're
going
to
get
that
information
out
to
the
public.
I
would
just
ask
everyone
to
continue
to
follow.
The
public
health
protocols
recognize
that
our
numbers
are
up
as
they
are
around
the
country.
A
Wear
a
mask
socially
distance,
don't
go
out
if
you
are
not
fee
or
if
you
are
not
feeling
well,
you
know
be
safe
for
your
family,
be
safe
for
your
community.
Thank
you,
dr
hubbard,
for
joining
us
today
and
for
participating
in
the
trial.
I
know
it
means
to
to
evanstonians
to
know
that
we
had
someone
in
our
own
community
who
was
part
of
that.
Thank
you,
ike
ogbo,
for
all
of
all
of
your
leadership.
A
I
will
say
on
behalf
of
someone
who's,
not
in
the
public
health
arena,
that
in
2020
it's
a
year
that
we
have
developed
a
deep,
deep
appreciation
for
all
essential
workers
and
for
scientists
and
for
public
health
departments
and
officials,
which
I
think
a
lot
of
people
probably
had
no
idea.
What
does
a
public
health
department
exactly
do
and
why
are
we
spending
this
money
on
them?
We
are
so
appreciative
for
what
you,
what
you
all
have
done
and
are
doing
to
help
us
get
out
of
this.